Precision Biosciences (DTIL) Times Interest Earned (2019 - 2026)
Precision Biosciences (DTIL) reported Times Interest Earned of -$29.18 for Q1 2026, up 53.28% year-over-year from -$19.04 in Q1 2025, and down 181.19% quarter-over-quarter from $35.94 in Q4 2025.
Precision Biosciences (DTIL) Times Interest Earned (2019 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 7 years of Times Interest Earned data on file, last reported at -$29.18 in Q1 2026.
- Times Interest Earned for Q1 2026 came in at -$29.18, up 53.28% year-over-year; the trailing twelve-month figure through Mar 2026 was -$28.36 (changed 0.49% YoY), and the FY2025 annual result was -$36.67, down 149.79% from the prior year.
- Times Interest Earned slipped to -$29.18 in Q1 2026 per DTIL's latest filing, from $35.94 in the prior quarter.
- Over five years, Times Interest Earned peaked at $43.12 in Q2 2024 and troughed at -$650.83 in Q1 2022.
- A 5-year average of -$73.0 and a median of -$29.18 in 2026 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned surged 862.04% in 2024, then sank 756.32% in 2025.
- A 5-year view of Times Interest Earned shows it stood at -$24.92 in 2022, then dropped by 3.22% to -$25.72 in 2023, then sank by 146.46% to -$63.38 in 2024, then surged by 156.71% to $35.94 in 2025, then plunged by 181.19% to -$29.18 in 2026.
- Business Quant data shows DTIL's Times Interest Earned at -$29.18 in Q1 2026, $35.94 in Q4 2025, and -$57.09 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Precision Biosciences | 168.99 Mn | 67.81 Mn | - | -29.18 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.18 |
| Dec 31, 2025 | 35.94 |
| Sep 30, 2025 | -57.09 |
| Jun 30, 2025 | -61.11 |
| Mar 31, 2025 | -62.46 |
| Dec 31, 2024 | -63.38 |
| Sep 30, 2024 | -83.11 |
| Jun 30, 2024 | 43.12 |
| Mar 31, 2024 | -7.29 |
| Dec 31, 2023 | -25.72 |
| Sep 30, 2023 | -21.46 |
| Jun 30, 2023 | -5.66 |
| Mar 31, 2023 | -25.58 |
| Dec 31, 2022 | -24.92 |
| Sep 30, 2022 | -36.24 |
| Jun 30, 2022 | -166.03 |
| Mar 31, 2022 | -650.83 |
| Dec 31, 2021 | -579.70 |
| Sep 30, 2021 | -209.85 |
| Jun 30, 2021 | 901.33 |